Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition

Eur J Cancer Care (Engl). 2007 May;16(3):289-90. doi: 10.1111/j.1365-2354.2006.00735.x.

Abstract

This paper reports the case of a 64-year-old man who was receiving parenteral nutrition after repeated operations due to stomach cancer. Olanzapine (orally disintegrating tablets) in combination with alprazolam was used successfully to relieve this terminally ill patient's anxiety and tension improving his relationship with his physicians and his daily life.

Publication types

  • Case Reports

MeSH terms

  • Administration, Sublingual
  • Alprazolam / administration & dosage*
  • Anti-Anxiety Agents / administration & dosage*
  • Anxiety Disorders / drug therapy*
  • Benzodiazepines / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Olanzapine
  • Parenteral Nutrition
  • Professional-Patient Relations
  • Quality of Life
  • Stomach Neoplasms / psychology*
  • Stomach Neoplasms / surgery
  • Terminally Ill

Substances

  • Anti-Anxiety Agents
  • Benzodiazepines
  • Olanzapine
  • Alprazolam